Loading...
ARIAD Pharmaceuticals, Inc.
ARIA•NASDAQ
$0.00
$0.00(0.00%)
ARIAD Pharmaceuticals, Inc. (ARIA) Stock Overview
Explore ARIAD Pharmaceuticals, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Stats data is not available for ARIAStats details for ARIA are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for ARIAAnalyst Recommendations details for ARIA are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Company Profile
ARIAD Pharmaceuticals, Inc. is a global oncology company focused on the discovery, development, and commercialization of medicines to transform the lives of cancer patients. The Company's approach to structure-based drug design has led to several molecularly targeted medicines for drug-resistant and difficult-to-treat cancers.
Founded
2001